Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States

Archives of Pediatrics and Adolescent Medicine

Volumn 166, Issue 4, 2012, Pages 350-355

  Zickafoose, Joseph S ^a   Benneyworth, Brian D ^a,b   Riebschleger, Meredith P ^a,b   Espinosa, Claudia M ^a,b   Davis, Matthew M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD HOSPITALIZATION; CROSS-SECTIONAL STUDY; DATA BASE; HOSPITAL DISCHARGE; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; INTUSSUSCEPTION; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INPATIENTS; INTUSSUSCEPTION; MALE; RETREATMENT; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 84859389496     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.1501     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention (CDC). Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48(43):1007.
2. Murphy BR, Morens DM, Simonsen L, Chanock RM, La Montagne JR, Kapikian AZ. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis. 2003;187(8):1301-1308. (Pubitemid 36442707)
3. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11-22. (Pubitemid 43048947)
4. Vesikari T, Matson DO, Dennehy P, et al Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23-33. (Pubitemid 43048948)
5. Belongia EA, Irving SA, Shui IM, et al Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010; 29(1):1-5.
6. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121(6):1206-1212.
7. Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011; 364(24):2283-2292.
8. Buttery JP, Danchin MH, Lee KJ, et al PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29(16):3061- 3066.
9. Centers for Disease Control and Prevention (CDC). Rotavirus vaccination coverage among infants aged 5 months: immunization information system sentinel sites, United States, June 2006-June 2009.MMWRMorb Mortal Wkly Rep. 2010; 59(17):521-524.
10. Bégué RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics. 2010;126(1):e40-e45.
11. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J. 2010; 29(6):489-494.
12. Staat MA, Payne DC, Donauer S, et al New Vaccine Surveillance Network (NVSN). Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics. 2011;128(2):e267-e275.
13. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201(11):1617-1624.
14. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J. 2011;30(1)(suppl):S56-S60.
15. Yen C, Tate JE, Wenk JD, Harris JM II, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics. 2011;127(1):e9-e15.
16. Introduction to the HCUP Kids' Inpatient Database (KID) 2009. Rockville, MD: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP); 2011.
17. The Kids' Inpatient Database. Healthcare Cost and Utilization Project (HCUP) Web site. www.hcup-us.ahrq.gov/kidoverview.jsp. Accessed June 30, 2011.
18. Welcome to HCUPnet. Healthcare Cost and Utilization Project (HCUP) Web site. http://hcupnet.ahrq.gov. Accessed June 30, 2011.
19. Cortese MM, Staat MA, Weinberg GA, et al. Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines. J Infect Dis. 2009;200(suppl 1):S264-S270.
20. Using the KIDS' Inpatient Database (KID) to Estimate Trends. Rockville, MD: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP); 2009. Report 2007-02. HCUP Methods Series.
21. Weisberg S. Applied Linear Regression. Hoboken, NJ:Wiley-Interscience; 2005.
22. Benneyworth BD, Gebremariam A, Clark SJ, Shanley TP, Davis MM. Inpatient health care utilization for children dependent on long-term mechanical ventilation. Pediatrics. 2011;127(6):e1533-e1541.
23. Resident population estimates. US Census Bureau, Population Division Web site. http://www.census.gov/popest/estimates.html. Published 2011. Accessed July 28, 2011.
24. Overview of the Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) Web site. www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 1, 2011.
25. Introduction to the HCUP Nationwide Inpatient Sample (NIS) 2009. Rockville, MD: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP); 2011.
26. Parashar UD, Holman RC, Cummings KC, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics. 2000; 106(6):1413-1421.
27. Tate JE, Simonsen L, Viboud C, et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 2008;121(5):e1125-e1132.
28. Greenberg HB. Rotavirus vaccination and intussusception: act two. N Engl J Med. 2011;364(24):2354-2355.
29. El-Hodhod MA, Nassar MF, Ezz El-Arab S, Ahmed EF. Rotavirus fecal antigen retrieval in infantile intussusception. Eur J Clin Microbiol Infect Dis. 2008;27 (9):879-881.
30. Robinson CG, Hernanz-Schulman M, Zhu Y, Griffin MR, Gruber W, Edwards KM. Evaluation of anatomic changes in young children with natural rotavirus infection: is intussusception biologically plausible? J Infect Dis. 2004;189(8):1382-1387. (Pubitemid 38543586)
31. Bines JE, Patel M, Parashar U. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis. 2009;200(suppl 1):S282-S290.
32. Bines JE, Kohl KS, Forster J, et al Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22(5-6):569-574. (Pubitemid 38114883)